Christine Matthews Net Worth

The estimated Net Worth of Christine Matthews is at least $5.49 Thousand dollars as of 6 June 2022. Ms. Matthews owns over 82 units of Zosano Pharma Corp stock worth over $2,342 and over the last 4 years she sold ZSAN stock worth over $3,147. In addition, she makes $0 as Chief Financial Officer and Principal Financial Officer at Zosano Pharma Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Matthews ZSAN stock SEC Form 4 insiders trading

Christine has made over 3 trades of the Zosano Pharma Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 82 units of ZSAN stock worth $58 on 6 June 2022.

The largest trade she's ever made was selling 8,116 units of Zosano Pharma Corp stock on 31 March 2022 worth over $1,704. On average, Christine trades about 1,238 units every 46 days since 2020. As of 6 June 2022 she still owns at least 4,183 units of Zosano Pharma Corp stock.

You can see the complete history of Ms. Matthews stock trades at the bottom of the page.

Christine Matthews biography

Christine E. Matthews serves as Chief Financial Officer, Principal Financial Officer of the Company. Christine Matthews has been appointed as Interim Chief Financial Officer of the Company effective 2/1/2020. She has served as the Company’s Vice President, Corporate Controller, since January 2019. From August 2015 to January 2019, Ms. Matthews served as an accounting and financial consultant with Resources Global Professionals (“RGP”). Prior to joining RGP, from September 2013 to June 2015, Ms. Matthews served as Senior Director of Finance at Cepheid, Inc., a biotechnology company. Ms. Matthews received a B.S. in Business Administration with an Emphasis in Accounting from the University of Colorado at Boulder.

How old is Christine Matthews?

Christine Matthews is 51, she's been the Chief Financial Officer and Principal Financial Officer of Zosano Pharma Corp since 2020. There are 6 older and 1 younger executives at Zosano Pharma Corp. The oldest executive at Zosano Pharma Corp is Dr. Donald J. Kellerman, 66, who is the VP of Clinical Devel. & Medical Affairs.

What's Christine Matthews's mailing address?

Christine's mailing address filed with the SEC is C/O ZOSANO PHARMA CORPORATION, 34790 ARDENTECH COURT, FREMONT, CA, 94555.

Insiders trading at Zosano Pharma Corp

Over the last 10 years, insiders at Zosano Pharma Corp have traded over $5,506,679 worth of Zosano Pharma Corp stock and bought 790,627 units worth $1,835,090 . The most active insiders traders include M James Barrett, Enterprise Associates 12, L..., and Steve Elms. On average, Zosano Pharma Corp executives and independent directors trade stock every 60 days with the average trade being worth of $44,258. The most recent stock trade was executed by Christine Matthews on 6 June 2022, trading 82 units of ZSAN stock currently worth $58.

What does Zosano Pharma Corp do?

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano's lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine.

Complete history of Ms. Matthews stock trades at Zosano Pharma Corp

Zosano Pharma Corp executives and stock owners

Zosano Pharma Corp executives and other stock owners filed with the SEC include:

• Steven Lo,
  Sr. VP of Operations, Pres, CEO & Director
• Dr. Donald J. Kellerman,
  VP of Clinical Devel. & Medical Affairs
• Kleanthis Xanthopoulos,
  Independent Director
• Kenneth Greathouse,
  Independent Director
• Steven Elms,
  Independent Director
• Joseph Hagan,
  Director
• Linda Grais,
  Director
• Thorsten von Stein,
  Chief Medical Officer
• Eric Scharin,
  Vice President - Technical Operations
• Dushyant Pathak,
  Senior Vice President - Business Development
• Christine Matthews,
  Chief Financial Officer, Principal Financial Officer
• Steven Lo,
  Chief Executive Officer, Director
• John Walker,
  Chairman of the Board
• Kristina Warga,
  VP & Corp. Controller
• Lu Liu,
  VP of Technical Operations
• Jeffrey L. Quillen,
  Sec.
• Hayley Lewis,
  Sr. VP of Operations
• Christine Matthews,
  Chief Financial Officer
• Capital Iv, Lp Aisling Capi...,
  
• Winnie Wing Kei Tso,
  Chief Financial Officer
• Georgia Erbez,
  Interim CFO
• Konstantinos Alataris,
  President
• M James Barrett,
  Director
• Enterprise Associates 12, L...,
  
• Troy Edward Wilson,
  Director
• Enterprise Associates 12, L...,
  
• Kathy M. Mc Gee,
  Director
• Capital Management, Llc Kaz...,
  
• Gregory David Kitchener,
  Chief Financial Officer
• Elaine Yang,
  Director
• Enterprise Associates 12, L...,
  
• Realty Trust Inc Bio Med Re...,
  
• Laxmi Peri,
  Sr. Vice President, Operations
• Hayley Lewis,
  See Remarks
• Steve Elms,
  Director
• Donald J Kellerman,
  VP, Clinical Dev & Med Affairs